Hollebecque, A., Borad, M., Sahai, V., Catenacci, D. V. T., Murphy, A., Vaccaro, G., Paulson, A., Oh, D., Féliz, L., Lihou, C., Zhen, H., & Abou-Alfa, G. K. (n.d.). 756PInterim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095485582.0x000039